Key Takeaways

  • Dopamine drives the motivation to pursue a goal, while endogenous opioid neurotransmitters generate the pleasure of actually reaching it.
  • Addictive substances hijack dopamine circuits to create compulsive pursuit, which explains why addicts chase outcomes they no longer enjoy.
  • Cognitive performance follows an inverted-U curve where raising dopamine levels helps people starting from a low baseline but impairs high performers.
  • Masud Husain actively advises high-performing university students to avoid cognitive stimulants because excess dopamine degrades executive function and working memory.

The Chemistry of Wanting Without Liking

Most founders assume that wanting something intensely means they will enjoy having it. Neuroscience shows this assumption is wrong. The brain handles the drive to acquire a reward and the pleasure of experiencing that reward through two distinct chemical circuits.

“There is this dissociation in the neuroscience literature between wanting the motivation to go and try and find that rewarding outcome versus liking the hedonic pleasure from getting it,” Husain explains. “Wanting pursuit of a goal is mediated or modulated at least by dopamine, whereas actually the liking, the pleasure you might get from an outcome is not. That seems to be related to opioid neurotransmitters in the brain.”

This biological split explains the mechanics of compulsive behavior. When you obsessively check metrics, respond to notifications, or chase new targets, your mesolimbic dopamine pathway is firing. You feel an intense craving to act. But once you achieve the outcome, the expected satisfaction often fails to register.

Addictive substances exploit this exact separation. “Almost every drug of addiction, whether we go from nicotine to alcohol to heroin to cocaine to amphetamine, almost every drug of addiction hijacks that dopamine system,” Husain notes. The brain becomes locked into pursuit mode, burning energy to acquire a stimulus that provides zero hedonic return.

The Inverted-U Trap for High Performers

When founders feel fatigued or face difficult cognitive tasks, the default reaction is often to reach for chemical acceleration: double espressos, modafinil, or prescription stimulants like Adderall.

Husain warns that this strategy backfires for ambitious people. Psychopharmacology operates on an inverted-U shaped curve. If your dopamine levels and cognitive baseline sit at the low end of the curve, a stimulant can nudge you toward the peak. But if you already operate with high executive baseline function, extra dopamine pushes you down the far slope into cognitive impairment.

“If you start from a low baseline of performance, you might get some positive boost,” Husain says. “It's quite small, but you might get it. But if you are actually quite a high performer, then you risk getting worse.”

When dopamine levels climb too high in the prefrontal cortex, working memory contracts, cognitive flexibility drops, and error rates rise. You feel intense focus, but your actual output quality deteriorates.

“I tell the students that I teach about this sort of stuff, you're probably not going to be in that low baseline state given where you are here at this university,” Husain points out. “Just think twice about taking some stimulant that you want to get a better grade because actually the evidence would be that you might get worse from doing it.”

What to Do With This

Run an energy audit on your high-stakes cognitive work this week. For your next three deep-work blocks, eliminate all exogenous stimulants beyond a single morning cup of coffee. Track your working memory and error rate during complex problem-solving. If your clarity improves without the extra chemical push, you were operating past the peak of your inverted-U curve.